{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:51:55Z","timestamp":1761929515439},"reference-count":43,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Parasitology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vetpar.2010.12.002","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T10:12:11Z","timestamp":1292321531000},"page":"305-315","source":"Crossref","is-referenced-by-count":21,"title":["Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole"],"prefix":"10.1016","volume":"177","author":[{"given":"C.","family":"Devine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Lanusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.I.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Trudgett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hoey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fairweather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetpar.2010.12.002_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0031182005007997","article-title":"Altered drug influx\/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes","volume":"131","author":"Alvarez","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetpar.2008.06.017","article-title":"Ketoconazole increases the plasma levels of ivermectin in sheep","volume":"157","author":"Alvinerie","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0020-7519(94)00105-W","article-title":"Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide","volume":"25","author":"Anderson","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.2042-7158.1996.tb03965.x","article-title":"Interaction between fenbendazole and piperonyl butoxide: pharmacokinetic and pharmacodynamic implications","volume":"48","author":"Benchaoui","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-3024.1980.tb00042.x","article-title":"Fasciola hepatica: changes in tegument during killing of adult flukes surgically transferred to sensitized rats","volume":"2","author":"Bennett","year":"1980","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/vr.113.14.315","article-title":"Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole","volume":"113","author":"Boray","year":"1983","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182008005222","article-title":"Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica","volume":"136","author":"Devine","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1017\/S003118200999148X","article-title":"Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole","volume":"135","author":"Devine","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0045","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00436-010-1806-1","article-title":"Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica","volume":"106","author":"Devine","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00436-010-1866-2","article-title":"Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole","volume":"107","author":"Devine","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0055","doi-asserted-by":"crossref","unstructured":"Devine, C., Brennan, G.P., Lanusse, C.E., Alvarez, L.I., Trudgett, A., Hoey, E.M., Fairweather, I. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica. Parasitology, in press, doi:10.1017\/S0031182010001125.","DOI":"10.1017\/S0031182010001125"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1079\/JOH2005298","article-title":"Triclabendazole: new skills to unravel an old(ish) enigma","volume":"79","author":"Fairweather","year":"2005","journal-title":"J. Helminthol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0022149X09321173","article-title":"Triclabendazole progress report, 2005\u20132009: an advancement of learning?","volume":"83","author":"Fairweather","year":"2009","journal-title":"J. Helminthol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0014-4894(86)90040-8","article-title":"Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide","volume":"62","author":"Fairweather","year":"1986","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0075","series-title":"Fasciolosis","first-page":"47","article-title":"Development of Fasciola hepatica in the mammalian host","author":"Fairweather","year":"1999"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vetpar.2008.04.011","article-title":"Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole","volume":"155","author":"Halferty","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetpar.2008.10.007","article-title":"The relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica","volume":"159","author":"Halferty","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2885.1987.tb00078.x","article-title":"The kinetics of triclabendazole disposition in sheep","volume":"10","author":"Hennessy","year":"1987","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0095","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.trstmh.2007.07.012","article-title":"Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica","volume":"101","author":"Keiser","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0034-5288(91)90082-Y","article-title":"Enhancement of the plasma concentration of albendazole sulfoxide in sheep following coadministration of parenteral netobimin and liver oxidase inhibitors","volume":"51","author":"Lanusse","year":"1991","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/00498259209053108","article-title":"Effects of methimazole on the kinetics of netobimin metabolites in cattle","volume":"22","author":"Lanusse","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/bdd.2510130204","article-title":"Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep","volume":"13","author":"Lanusse","year":"1992","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03602539308993977","article-title":"Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants","volume":"25","author":"Lanusse","year":"1993","journal-title":"Drug. Metab. Rev."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2885.1992.tb01016.x","article-title":"Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment","volume":"15","author":"Lanusse","year":"1992","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0034-5288(95)90106-X","article-title":"Influence of the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep","volume":"58","author":"Lanusse","year":"1995","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-4017(97)00177-5","article-title":"Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime","volume":"75","author":"L\u00f3pez-Garc\u00eda","year":"1998","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetpar.2008.01.022","article-title":"Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha","volume":"153","author":"McConville","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetpar.2009.02.004","article-title":"An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica","volume":"162","author":"McConville","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0145","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00436-009-1453-6","article-title":"Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha","volume":"105","author":"McConville","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0150","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1124\/dmd.30.11.1230","article-title":"Fenbendazole pharmacokinetics, metabolism, and potentiation in horses","volume":"30","author":"McKellar","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00436-003-0930-6","article-title":"Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax)","volume":"91","author":"McKinstry","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0160","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00436-007-0564-1","article-title":"Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax)","volume":"101","author":"McKinstry","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00436-003-0863-0","article-title":"Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes","volume":"91","author":"Meaney","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00436-003-1036-x","article-title":"Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following treatment with clorsulon","volume":"92","author":"Meaney","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(03)00369-7","article-title":"Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors","volume":"263","author":"Merino","year":"2003","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-003-1003-6","article-title":"The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica","volume":"92","author":"Robinson","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2885.2002.00365.x","article-title":"Plasma achiral and chiral pharmacokinetic behavior of intravenous oxfendazole co-administered with piperonyl butoxide in sheep","volume":"25","author":"S\u00e1nchez","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2746\/0425164054530669","article-title":"Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses","volume":"37","author":"S\u00e1nchez-Bruni","year":"2005","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0031182000077428","article-title":"The effect of the sulphoxide metabolite of triclabendazole (\u2018Fasinex\u2019) on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica","volume":"108","author":"Stitt","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.vetpar.2010.12.002_bib0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vetpar.2010.05.012","article-title":"Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host","volume":"172","author":"Toner","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2885.2006.00735.x","article-title":"Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep","volume":"29","author":"Virkel","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2885.2008.01006.x","article-title":"Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep","volume":"32","author":"Virkel","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2010.12.002_bib0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00436-004-1222-5","article-title":"Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro","volume":"94","author":"Walker","year":"2004","journal-title":"Parasitol. Res."}],"container-title":["Veterinary Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401710007090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401710007090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T08:21:52Z","timestamp":1544084512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304401710007090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":43,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0304401710007090"],"URL":"https:\/\/doi.org\/10.1016\/j.vetpar.2010.12.002","relation":{},"ISSN":["0304-4017"],"issn-type":[{"value":"0304-4017","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}